Scandinavian Medical Solutions AS (OCSE:SMSMED) EBIT: kr-7.6 Mil (TTM As of Mar. 2026)


OCSE:SMSMED Scandinavian Medical Solutions AS OCSE:SMSMED
81 GF Score
Price kr2.90
GF Value kr6.23
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Scandinavian Medical Solutions AS EBIT?

Scandinavian Medical Solutions AS OCSE:SMSMED -0.34% 81 EBIT is kr-7.6 Mil as of Mar. 2026. GuruFocus rates OCSE:SMSMED with a GF Score™ of 81/100 and a GF Value™ of kr6.23 (Possible Value Trap). The stock has 7 warning signs investors should review.

Scandinavian Medical Solutions AS's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was kr-11.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-7.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Scandinavian Medical Solutions AS's annualized ROC % for the quarter that ended in Mar. 2026 was -11.39%. Scandinavian Medical Solutions AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -16.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Scandinavian Medical Solutions AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -4.94%.

Scandinavian Medical Solutions AS  (OCSE:SMSMED) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Scandinavian Medical Solutions AS's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-24.094 * ( 1 - 23.42% )/( (153.738 + 170.301)/ 2 )
=-18.4511852/162.0195
=-11.39 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=205.858 - 49.971 - ( 2.149 - max(0, 91.026 - 141.81+2.149))
=153.738

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=196.673 - 24.923 - ( 1.449 - max(0, 88.769 - 129.388+1.449))
=170.301

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Scandinavian Medical Solutions AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-23.552/( ( (62.637 + max(77.427, 0)) + (65.856 + max(74.664, 0)) )/ 2 )
=-23.552/( ( 140.064 + 140.52 )/ 2 )
=-23.552/140.292
=-16.79 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22.717 + 106.435 + 6.117) - (49.971 + 0 + 7.871)
=77.427

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(16.576 + 98.36 + 9.575) - (24.923 + 0 + 24.924)
=74.664

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Scandinavian Medical Solutions AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-7.57/153.168
=-4.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian Medical Solutions AS EBIT Related Terms

Scandinavian Medical Solutions AS EBIT Historical Data

* Premium members only.

The historical data trend for Scandinavian Medical Solutions AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian Medical Solutions AS EBIT Chart

Scandinavian Medical Solutions AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT
Get a 7-Day Free Trial 11.08 14.97 16.77 15.30 2.37

Scandinavian Medical Solutions AS Semi-Annual Data
Sep19 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.78 10.52 -1.84 4.21 -11.78

OCSE:SMSMED vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Scandinavian Medical Solutions AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scandinavian Medical Solutions AS EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scandinavian Medical Solutions AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Scandinavian Medical Solutions AS's EV-to-EBIT falls into.


OCSE:SMSMED
81GF Score
Scandinavian Medical Solutions AS OCSE:SMSMED
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scandinavian Medical Solutions AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-7.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-7.6 Mil mean?
Scandinavian Medical Solutions AS (OCSE:SMSMED) has a EBIT of kr-7.6 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Scandinavian Medical Solutions AS.
Is Scandinavian Medical Solutions AS's EBIT too high?
Scandinavian Medical Solutions AS's current EBIT is kr-7.6 Mil. Overall, Scandinavian Medical Solutions AS has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scandinavian Medical Solutions AS's EBIT compare to ABT and SYK?
Scandinavian Medical Solutions AS's EBIT of kr-7.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Scandinavian Medical Solutions AS. Scandinavian Medical Solutions AS's current EBIT is kr-7.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scandinavian Medical Solutions AS stock overvalued right now?
Based on GuruFocus' analysis, Scandinavian Medical Solutions AS (OCSE:SMSMED) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.23, compared to a current price of kr2.90 — trading 53.5% below its estimated fair value. The current EBIT is kr-7.6 Mil. Scandinavian Medical Solutions AS's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Scandinavian Medical Solutions AS (OCSE:SMSMED), the current EBIT is kr-7.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scandinavian Medical Solutions AS (OCSE:SMSMED) Overvalued in 2026?

Based on GuruFocus' analysis, Scandinavian Medical Solutions AS stock appears to be undervalued. The current stock price of kr2.90 is trading 53.5% below its estimated GF Value™ of kr6.23. GuruFocus considers Scandinavian Medical Solutions AS to be Possible Value Trap.

Key valuation signals for OCSE:SMSMED:

  • EBIT: kr-7.6 Mil
  • GF Value™: kr6.23 vs. price of kr2.90 (53.5% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the OCSE:SMSMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scandinavian Medical Solutions AS Business Description

Other Exchanges K41:Germany
Address Gasvaerksvej 48, 1st Floor, Aalborg, DNK, 9000
Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units.
81GF Score

Get the complete analysis for OCSE:SMSMED

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.90
Price
kr6.23
GF Value